DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
P•• P••••• T•••• I•••••••••
P•••••ceuticalsgroup grade Aon a schedule nowsponsor unattributed
Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
$-4,000
n/a on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Feb 13, 2032
no dated debt inside 24 months
On the tape since
Sep 30, 2025
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien revolver first lien | unknown | n/a | SOFR+475 bp | Feb 13, 2032 | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| M••••• A••••• I••••••••• P•••••• L•••••• | revolver first lien First Lien Secured Debt - Revolver S+475, 0.75% Floor Maturity Date 02/13/32 | n/a | $-4,000 400c | SOFR+475 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $0 | $-4,000 | 400c | 0 |
| Mar 31, 2026 | 1 | $10,000 | $7,000 | 78c | 0 |
| Dec 31, 2025 | 1 | $14,000 | $13,000 | 100c | 0 |
| Sep 30, 2025 | 1 | $0 | $-1,000 | 100c | 0 |
What changed
- Marked down (one lender)Mar 31, 2026
- New borrower on a BDC scheduleSep 30, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- PAI PHARMA TOTALderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- P•••••ceuticalsreportedas one filer wrote it